Page last updated: 2024-10-28
ibudilast and Sepsis
ibudilast has been researched along with Sepsis in 1 studies
Sepsis: Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK.
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Kadota, N | 1 |
| Yoshida, A | 1 |
| Sawamoto, A | 1 |
| Okuyama, S | 1 |
| Nakajima, M | 1 |
Other Studies
1 other study available for ibudilast and Sepsis
| Article | Year |
|---|---|
Ibudilast Reduces IL-6 Levels and Ameliorates Symptoms in Lipopolysaccharide-Induced Sepsis Mice.
Topics: Animals; Anti-Inflammatory Agents; Interleukin-6; Lipopolysaccharides; Mice; Plasminogen Activator I | 2022 |